参考文献/References:
[1] BAUR D M,KLOTSCHE J,HAMNVIK O P,et al. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort[J]. Metabolism:clinical and experimental,2011,60(10):1363-1371.
[2]CHEN T W,LIANG Y N,FENG D,et al. Metformin inhibits proliferation and promotes apoptosis of HER2 positive breast cancer cells by downregulating HSP90[J]. Journal of BUON:official journal of the Balkan Union of Oncology,2013,18(1):51-56.
[3]朱智峰,梁琳琅. 二甲双胍对结肠癌细胞增殖、周期及凋亡的影响[J]. 中国医科大学学报,2012,41(2):51-56.
[4]薛知新,钟捷,赵丹瑜,等. 二甲双胍对AGS胃癌细胞生长侵袭的抑制作用[J]. 世界华人消化杂志,2010,18(19):1974-1978.
[5]SIVEEN K S,SIKKA S,SURANA R,et al. Targeting the STAT3 signaling pathway in cancer:role of synthetic and natural inhibitors[J]. Biochimica et biophysica acta,2014,1845(2):136-154.
[6]ZHANG X,ZHANG J,WEI H,et al. STAT3-decoy oligodeoxynucleotide inhibits the growth of human lung cancer via down-regulating its target genes[J]. Oncology reports,2007,17(6):1377-1382.
[7]DARNELL J E. STATs and gene regulation[J]. Science,1997,277(5332):1630-1635.
[8]WANG X H,LIU B R,QU B,et al. Silencing STAT3 may inhibit cell growth through regulating signaling pathway,telomerase,cell cycle,apoptosis and angiogenesis in hepatocellular carcinoma:potential uses for gene therapy[J]. Neoplasma,2011,58(2):158-171.
[9]BOLLRATH J,PHESSE T J,VON BURSTIN V A,et al. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis[J]. Cancer cell,2009,15(2):91-102.
[10]KIUCHI N,NAKAJIMA K,ICHIBA M,et al. STAT3 is required for the gp130-mediated full activation of the c-myc gene[J]. Journal of experimental medicine,1999,189(1):63-73.
[11]ASGEIRSSON K S,OLAFSDOTTIR K,JONASSON J G,et al. The effects of IL-6 on cell adhesion and e-cadherin expression in breast cancer[J]. Cytokine,1998,10(9):720-728.
[12]杨佳华,刘颖斌,董平. 上皮间质细胞转化与肿瘤细胞侵袭转移的关系[J]. 中华医学杂志,2011,91(8):572-574.
[13]ZHAO Z,CHENG X,WANG Y,et al. Metformin inhibits the IL-6-induced epithelial-mesenchymal transition and lung adenocarcinoma growth and metastasis[J]. PloS one,2014,9(4):e95884.
[14]KASTRITIS E,CHARIDIMOU A,VARKARIS A,et al. Targeted therapies in multiple myeloma[J]. Targeted oncology,2009,4(1):23-36.
[15]WU D,CHENG J,SUN G,et al. p70S6K promotes IL-6-induced epithelial-mesenchymal transition and metastasis of head and neck squamous cell carcinoma[J]. Oncotarget,2016,7(24):36539-36550.
[16]IWATSUKI M,MIMORI K,YOKOBORI T,et al. Epithelial-mesenchymal transition in cancer development and its clinical significance[J]. Cancer science,2010,101(2):293-299.
[17]BAILEY C J,TURNER R C. Metformin[J]. The New England journal of medicine,1996,334(9):574-579.
[18]SIKKA A,KAUR M,AGARWAL C,et al. Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation[J]. Cell cycle,2012,11(7):1374-1382.